Huperzine A
Chinese RCTs show Huperzine A improved memory and learning in Alzheimer's patients (Xu et al., 1995: 58% vs 36% improved at 200mcg/day over 8 weeks) and in adolescent students (Sun et al., 1999: 100mcg/day for 4 weeks). A 2013 meta-analysis of 20 RCTs found significant benefits in Alzheimer's disease, but rated most trials at high risk of bias; the 2008 Cochrane review concluded the evidence is inadequate to recommend it, and a 2012 Cochrane review found no eligible trials in mild cognitive impairment. A 2019 RCT after traumatic brain injury found no memory benefit over placebo.
Evidencia revisada el
Mecanismo de acción
Huperzine A is extracted from Huperzia serrata (Chinese club moss). It is a potent, reversible acetylcholinesterase inhibitor — meaning it blocks the enzyme that breaks down acetylcholine, effectively increasing acetylcholine levels throughout the brain. This makes it one of the most powerful natural cholinergic compounds.
Resumen de evidencia clínica
Chinese RCTs show Huperzine A improved memory and learning in Alzheimer's patients (Xu et al., 1995: 58% vs 36% improved at 200mcg/day over 8 weeks) and in adolescent students (Sun et al., 1999: 100mcg/day for 4 weeks). A 2013 meta-analysis of 20 RCTs found significant benefits in Alzheimer's disease, but rated most trials at high risk of bias; the 2008 Cochrane review concluded the evidence is inadequate to recommend it, and a 2012 Cochrane review found no eligible trials in mild cognitive impairment. A 2019 RCT after traumatic brain injury found no memory benefit over placebo.
Matriz de efectos en humanos
Basado solo en ensayos clínicos en humanos. Se excluyen los datos en animales e in vitro.
| Efecto | Evidencia | Magnitud | Estudios |
|---|---|---|---|
| Memory Recall | moderada | Moderado | 4 |
| Acetylcholine Preservation | sólida | Grande | 2 |
| Learning Speed | preliminar | Moderado | 1 |
| Alzheimer's Symptom Reduction | moderada | Moderado | 3 |
Clave de evidencia: Sólida = varios ECA consistentes · Moderada = ECA más pequeños o menos numerosos · Preliminar = ensayos iniciales o n pequeño · Mixta = resultados contradictorios
Beneficios documentados
- Acetylcholine preservation (established mechanism)
- Cognition and daily function in Alzheimer's disease (low-quality trials)
- Memory and learning in one student RCT
Efectos secundarios y precauciones
- Adverse events in Alzheimer's trials were mild and not significantly different from placebo (2008 Cochrane review)
- Overdose risk with other cholinergics
- GI discomfort at high doses
- Not suitable for people on cholinesterase inhibitor drugs
Cómo tomarlo
Recomendaciones de combinación
Ingredientes que se combinan bien con Huperzine A y por qué.
Bacopa works via synaptic density (non-cholinergic mechanism); Huperzine A works via acetylcholine preservation. No mechanism overlap. A powerful memory stack where both sides work independently.
Lion's Mane supports long-term neurogenesis via NGF; Huperzine A supports acetylcholine by slowing its breakdown. Different mechanisms with no conflict.
Preguntas frecuentes
Does Huperzine A need to be cycled?
There is no trial evidence either way. The clinical trials gave it daily for 4–16 weeks, and the 2008 Cochrane review found adverse events were mild and no more common than on placebo. No human trial has tested a cycling schedule. Cholinergic side effects — nausea, sweating, excessive salivation, muscle twitching — are the thing to watch for; stop or reduce the dose if they appear.
Is 100mcg the same as 100mg? The label looks confusing.
No — mcg (micrograms) and mg (milligrams) are different by a factor of 1000. Huperzine A is dosed in micrograms (mcg). A 200mcg dose is 0.2mg. This is correct and intentional — Huperzine A is extremely potent. If a product claims a dose in milligrams (e.g. "100mg"), read the label carefully — it likely means 100mcg (0.1mg). A true 100mg dose of Huperzine A would be catastrophically overdosed.
Can I take Huperzine A with Alpha-GPC?
Technically yes, but with significant caution. Alpha-GPC increases acetylcholine synthesis; Huperzine A prevents its breakdown. The combination can easily cause cholinergic overload, and no trial has tested it. If combining, use low doses of each and start with one at a time before combining. Watch carefully for early overload symptoms: nausea, headache, excessive salivation.
Is Huperzine A safe for young healthy adults?
Huperzine A's research base is mostly in Alzheimer's patients; the only healthy-population RCT found was a 4-week study in 68 adolescent students at 100mcg/day. The key risks in healthy users are dosing errors (confusing mcg and mg) and combining with other cholinergics. Long-term safety in healthy adults has not been studied.
Huperzine A en América Latina
Productos disponibles en América Latina
Ninguno de los stacks que hemos auditado figura todavía en nuestro catálogo para América Latina.
ANVISA / COFEPRIS / INVIMA
Nota regulatoria
Esta página es contenido editorial con fines educativos y no constituye consejo médico. Los suplementos alimenticios están regulados por agencias nacionales: la Agência Nacional de Vigilância Sanitária (ANVISA) en Brasil bajo RDC 243/2018, la Comisión Federal para la Protección contra Riesgos Sanitarios (COFEPRIS) en México, y el Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA) en Colombia. En Argentina, la Disposición 2105/2022 de la Administración Nacional de Medicamentos, Alimentos y Tecnología Médica (ANMAT) prohíbe siete productos concretos de las marcas Newmind y PURENOOTROPICS (Noopept, F-Phenibut y Bacopa) — no recomendamos productos con Noopept ni F-Phenibut a lectores en Argentina. Aviso para lectores en Brasil: el 2 de julio de 2026, ANVISA informó que algunos péptidos inyectables promocionados en internet, entre ellos GHK-Cu, BPC-157, TB-500, CJC-1295 e ipamorelin, no están regularizados en ninguna categoría (alimento, medicamento, cosmético ni suplemento alimentario) y son ilegales para cualquier uso en salud, incluido el estético. No enlazamos ni recomendamos proveedores que realicen envíos de formulaciones inyectables a Brasil. Consulte siempre a un profesional de la salud calificado antes de comenzar cualquier suplemento. / This page is editorial and not medical advice. Supplements are regulated by national agencies: the Agência Nacional de Vigilância Sanitária (ANVISA) in Brazil, the Comisión Federal para la Protección contra Riesgos Sanitarios (COFEPRIS) in Mexico, and the Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA) in Colombia. In Argentina, ANMAT Disposition 2105/2022 prohibits seven specific products of the Newmind and PURENOOTROPICS brands (Noopept, F-Phenibut and Bacopa) — we do not recommend products containing Noopept or F-Phenibut to Argentine readers. Brazil notice: on 2 July 2026, ANVISA stated that some injectable peptides promoted online, including GHK-Cu, BPC-157, TB-500, CJC-1295 and ipamorelin, are not regularised in any category (food, medicine, cosmetic or food supplement) and are illegal for any health use, including aesthetic use. We do not link to or recommend vendors that ship injectable formulations to Brazil. Consult a qualified healthcare professional before starting any supplement.
Fuentes (6)ampliar
- PMID 24086396Huperzine A for Alzheimer's disease: a systematic review and meta-analysis of randomized clinical trials (2013)
- PMID 18425924Huperzine A for Alzheimer's disease (2008)
- PMID 23235666Huperzine A for mild cognitive impairment (2012)
- PMID 10678121Huperzine-A capsules enhance memory and learning performance in 34 pairs of matched adolescent students (1999)
- PMID 8701750Efficacy of tablet huperzine-A on memory, cognition, and behavior in Alzheimer's disease (1995)
- PMID 31638455Huperzine A for the treatment of cognitive, mood, and functional deficits after moderate and severe TBI (HUP-TBI): results of a Phase II randomized controlled pilot study (2019)